These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 3099236)

  • 21. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
    Ciccarelli E; Ghigo E; Miola C; Gandini G; Muller EE; Camanni F
    Clin Endocrinol (Oxf); 1990 May; 32(5):583-92. PubMed ID: 2114241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma.
    Eljarmak D; Lis M; Cantin M; Carrière PD; Collu R
    Horm Res; 1985; 21(3):160-7. PubMed ID: 3997065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
    Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
    J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of prolactinoma in management of anovulation].
    Kurachi K; Aono T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1581-6. PubMed ID: 7130780
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyrotropin-and prolactin--secreting pituitary tumor dissociated hormonal response to bromocriptine.
    Jap TS; Kwok CF; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Mar; 45(3):191-5. PubMed ID: 2168264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA; Sherman BM; Chapler FK; VanGilder J
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperprolactinemia in chronic renal insufficiency: an interesting model of hypothalamo-hypophyseal dysfunction].
    De Leo V; D'Ambrogio G; De Leo M; Franchi F; Inaudi P; La Rosa R; D'Antona N; Genazzani AR
    Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1102-8. PubMed ID: 6414492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
    Gross DJ; Halperin Y; Gomori JM; Glaser B
    Isr J Med Sci; 1989 May; 25(5):256-60. PubMed ID: 2498229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF rhinorrhea after bromocriptine for prolactinoma.
    Baskin DS; Wilson CB
    N Engl J Med; 1982 Jan; 306(3):178. PubMed ID: 7054671
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prolactinomas and "idiopathic" hyperprolactinemia. Case series].
    Volpe A; Grasso A; Oliva A; Bramanti P; Leggiadro N; Musolino R; Meduri M
    Riv Neurol; 1980; 50(5):350-61. PubMed ID: 6781058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.